Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.455
https://www.valueinhealthjournal.com/article/S1098-3015(17)30789-1/fulltext
Title :
Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30789-1&doi=10.1016/j.jval.2017.08.455
First page :
A479
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
432